Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Learn how SGLT2 inhibitors affect hemoglobin and hematocrit, and what a JAMA meta-analysis reveals about possible heart and kidney benefits.
Read More »The SGLT2 Hemoglobin Effect: A Clue to Cardiorenal Protection?
© Copyright 2026 DiabetesInControl.com, All Rights Reserved.